baber/WOPTO huggingface dataset:
Patent CA-2571708-C (CA)
Title: Ignition bypass system
Inventor: BROWN CHARLES BARROY JR
IPC: B60R25/00
Filed: 2006-12-19
Granted: 2012-09-25
Abstract: A system and method for bypassing the ignition switch and controlling operation of an engine and an accessory drive of a vehicle, the system comprising an ignition switch, a user-activated secondary switch, a control logic circuit, and a third switch. The ignition switch controls operation of the engine that enables the engine to operate when the ignition switch is in an ON state. The user-activated secondary switch makes a connection in a parallel electrical power supply circuit to the engine and vehicle accessory drive, when the secondary switch is in the CLOSED state. The control logic circuit is responsive to the ignition switch, the secondary switch, and a user-activated vehicle control device. The third switch is associated with a user-activated vehicle control device wherein the third switch causes the logic circuit to interrupt the parallel electrical power supply circuit, when the user- activated vehicle control device is activated.
Patent CA-2579486-C (CA)
Inventor: YANG ALAIN
IPC: E04B1/74
Filed: 2005-09-09
Granted: 2015-04-21
Abstract: The invention relates to curing a binder on fibrous insulation wherein, heated gas flows as a ratio of, an upward flow into the fibrous insulation, and a downward flow into the fibrous insulation, to heat the binder to its curing temperature; and the binder is cooled, thereby curing at least a portion of the binder to a thermoset state. When a remainder of the binder remains uncured, another stage of heating the binder with a ratio of heated gas followed by cooling, will cure the remainder of the binder.
Patent CA-2581955-C (CA)
Inventor: SHENFIELD MICHAEL
IPC: H04L29/02
Filed: 2007-03-16
Granted: 2012-11-13
Abstract: A method and system of optimizing content delivery at a processing element in a dynamic content delivery architecture, the method having the steps of: receiving a content and metadata envelope at the processing element; checking the content and metadata envelope to determine whether the content and metadata envelope includes metadata for the processing element; if the content envelope contains metadata for the processing element, extracting and caching the metadata; if the content envelope does not contain metadata for the processing element, retrieving metadata for a content provider associated with the content from a cache on the processing element; and applying the extracted or retrieved metadata to the content and metadata envelope.
Patent CA-2582041-C (CA)
Inventor: ROIZ LEVAVA
IPC: A61K31/7088
Filed: 2005-09-28
Granted: 2015-08-04
Abstract: The cloning and heterologous expression of human T2 RNase6PL are disclosed.  Further disclosed are methods for preventing, inhibiting and/or reversing cell motility, actin filament assembly or disassembly, proliferation, colonization, differentiation, accumulation and/or development of abnormal cells in a subject is disclosed. The methods are effected by administering to the subject a therapeutically effective amount of a RNase6PL ribonuclease or close homologues thereof.
Patent CA-2583095-C (CA)
Inventor: GOUGH NIGEL
IPC: A61B5/00
Filed: 2005-10-19
Granted: 2015-04-07
Abstract: A device comprising a light transmission and detection system having transducers (1, 2, 7, 8), control means (5) and output means (7). The transducers are placed at various sites on the body of a patient and the light absorbed and/or reflected at these sites is measured and signals related to vasomotor activity are collected. The output can take the form of a detailed display of the vasomotor signals collected from the transducers (1, 2, 7, 8) to a simple indication of a condition present or absent. For, example, the presence of a unilateral DVT can be detected by measuring the dissimilarity between two transducer signals from the soles of a patient's feet. The invention can also be used to provide an indication or not of for example, DVT  and diabetic peripheral neuropathy.
Patent CA-2588467-C (CA)
Title: Solid skin care composition comprising multiple layers based on water-in-oil emulsions
Inventor: TANIGUCHI TOSHIYA
IPC: A61K8/06
Filed: 2006-09-01
Granted: 2011-01-11
Abstract: Disclosed is a solid skin care composition comprising: (a) a first layer which is solid at 45~C and which is a water-in-oil emulsion; and (b) a second layer which is solid at 45~C and which is a water-in-oil emulsion comprising a benefit agent; wherein the first layer and the second layer have a different composition; and wherein the first layer and the second layer are provided in the same package in a manner such that the first layer and the second layer can be simultaneously applied.
Patent CA-2590758-C (CA)
Inventor: MARTIN ERIC
IPC: G02B6/255
Filed: 2007-06-07
Granted: 2015-10-06
Abstract: The present invention relates to fibre optics and more particularly to flexible, durable, fibre optic splices, and methods of installing such splices. One embodiment of the invention comprises a fibre optic splice comprising: a flexible central tensile member; a flexible helical wrapping positioned about the flexible central tensile member; and an outer protective jacket positioned about the flexible helical wrapping. The flexible central tensile member and the flexible helical wrapping define a splice enclosure to accommodate optical fibres of the splice, at least a portion of the optical fibres being arranged in a generally helical orientation within the splice enclosure.
Patent CA-2591840-C (CA)
Inventor: CHEN YUAN-TSONG
IPC: C12Q1/68
Filed: 2005-12-21
Granted: 2012-07-10
Abstract: We discovered that a polymorphism in the promoter of the VKORCI gene is associated with warfarin sensitivity. This polymorphism can explain both the inter~individual and inter-ethnic differences in warfarin dose requirements.  Furthermore, the polymorphism is also associated with promoter activity. Thus, the promoter sequence or activity of the VKORCI gene of a subject can be used to predict how much warfarin should be prescribed for the subject. Relevant methods and compositions are provided.
Patent CA-2596974-C (CA)
Inventor: HEHL KARL
IPC: B29C45/67
Filed: 2006-02-07
Granted: 2013-05-21
Abstract: The invention relates to an injection moulding machine comprising a machine frame (10), an injection moulding unit (S, S') and a mould closing unit (F).  Said mould closing unit (F) is provided with a stationary element and a movable mould support (12) which are fixed thereto, wherein said movable mould support (12) is mounted in front of the stationary element and is displaceable on a guiding elements (11) in the direction of closing (s-s) in and out of a positive locking, wherein the mould closing unit (f) is provided with, fixed thereto, the machine frame (10) or at least a part thereof in the form of a stationary mould carrier (13) and the movable mould support (12) displaceable with respect to said stationary mould carrier (13) on the guiding elements (11). The other parts of the mould closing unit (F) is movable in a positive locking with respect to the stationary mould carrier (13). The mould closing unit (F) comprises a drive unit for displacing the movable mould support (12), and is actively connected to the stationary mould carrier (13) and to the movable mould support (12) by means of at least one force-transmission element. One end of the drive element (A) is hinged about the machine frame (10) or the stationary mould carrier (13) and the other end thereof is hinged about a support plate (14) which is movable in the direction of closing (s-s) and is connected to the force-transmission element. In the preferred embodiment, said force-transmission element is embodied in the form of a stirrup piece (15).
Patent CA-2600757-C (CA)
Inventor: BEAVERS LISA SELSAM
IPC: A61P25/00
Filed: 2006-03-13
Granted: 2014-02-18
Abstract: The present invention discloses novel compounds of Formula (I) or pharmaceutically acceptable salts thereof which have histamine-H3 receptor antagonist or inverse agonist activity, as well as methods and intermediates for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of using them to treat obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases.
Patent CA-2602463-C (CA)
Inventor: JAKOBSEN BENT KARSTEN
IPC: C12N15/12
Filed: 2006-03-29
Granted: 2018-09-04
Abstract: The present invention provides TCRs having an affinity (KD) of less than or equal to l~M, and/or an off-rate (koff) of 1x10-3 S-1 or slower, for the SLYNTVATL-HLA- A* 0201 complex PROVIDED THAT when the said TCR is presented by cell and comprises SEQ ID NOs: 1 and 2, the cell is not a native T cell. Such TCRs are useful, either alone or associated with a therapeutic agent, for targeting HIV infected cells presenting that complex.
Patent CA-2603434-C (CA)
Inventor: KIEST LARRY W JR
IPC: F16L55/179
Filed: 2006-02-27
Granted: 2010-11-09
Abstract: L'invention porte sur un procédé d'identification de conduite latérale qui consiste à imprimer des indices d'identification sur la surface interne d'un ensemble de revêtement positionné à côté de la conduite latérale. L'appareil comprend l'ensemble de revêtement sur lequel sont placés des indices d'identification visibles depuis l'intérieur de la conduite principale.
Patent CA-2604417-C (CA)
Title: Vanne de decharge pour souffleuse de materiaux isolants
Inventor: JOHNSON MICHAEL W
IPC: E04F21/08
Filed: 2007-09-26
Granted: 2016-04-19
Abstract: Une machine servant à distribuer de lisolant soufflé comprend une chambre de déchiquetage comportant une extrémité de sortie, une pluralité de déchiqueteuses configurées pour déchiqueter et défaire lisolant soufflé et un mécanisme d'évacuation installé à lextrémité de sortie de la chambre de déchiquetage et configuré pour distribuer lisolant soufflé dans un flux dair. Le mécanisme d'évacuation comprend un logement et une pluralité de mécanismes de déflecteurs étanches installés en vue dune rotation. Les mécanismes de déflecteurs étanches sont configurés pour faire l'étanchéité contre le logement au moment où les mécanismes de déflecteurs étanches tournent. Le logement comprend un segment excentrique se prolongeant du logement. Un souffleur est présent et configuré pour fournir le flux dair qui circule dans le mécanisme dévacuation. Les mécanismes de déflecteurs étanches sécartent du logement lorsque les mécanismes de déflecteurs étanches tournent dans le segment excentrique.
Patent CA-2607908-C (CA)
Inventor: BARLIER CLAUDE
IPC: G05B19/4099
Filed: 2006-03-27
Granted: 2017-10-03
Abstract: The invention relates to a method for the production of a part having fluid conduits or channels extending therethrough, such as, but not exclusively, for the production of a mould comprising channels or conduits for the circulation and/or transfer of a fluid from the moulding section to the non-moulding section and vice versa. The invention is characterised in that the part is designed and produced using a Stratoconception® method which is based on a principle by which the part is decomposed along a set of interlayer planes (Pi) into a succession of layers (...6i, 6i+1) which, once assembled, form the part. The invention is also characterised in that channels (2) are provided at the different interlayer planes (Pi) for the passage of a fluid through the part (1). The invention also relates to the parts thus obtained.
Patent CA-2610935-C (CA)
Title: A secondary package
Inventor: CERVENY JEAN-PAUL
IPC: B65D71/08
Filed: 2006-06-02
Granted: 2012-01-17
Abstract: The invention relates to a secondary package for gathering a plurality of primary packages, comprising an envelope that surrounds the plurality of primary packages so as to tightly hold the latter together, said envelope comprising a base supporting the primary packages, lateral sides, and a top side, characterized in that : (i) said base comprises a medium folding line that pivotally connects two halves of the base supporting the primary packages, and further comprises a carrying handle that is disposed vertically along the medium folding line, and (ii) the lateral sides and the top side of the envelope comprise a transversal precut in the region of the medium folding line, and so that when the envelope is open along said precut, it still holds tightly the primary packages disposed on each of the two base halves and said halves can be pivoted around the medium folding line to allow complete access to the carrying handle.
Patent CA-2611078-C (CA)
Title: Systemes de champ de drainage et procedes pour les mettre en place
Inventor: RING CARL
IPC: E02B11/00
Filed: 2006-06-01
Granted: 2015-07-07
Abstract: La présente invention concerne un système de champ de drainage comprenant une tranchée qui présente deux parois latérales et un fond, une ou plusieurs conduites de drainage perforées, et un ou plusieurs faisceaux d'agrégats confinés placés au voisinage de la conduite de drainage. Dans une application, un système comprend deux faisceaux d'agrégats disposés sur le fond d'une tranchée, une conduite de drainage étant placée entre les deux faisceaux sur le fond de la tranchée. Dans une application, une conduite de drainage est placée sur le dessus de deux faisceaux d'agrégats confinés qui ont été placés côte à côte dans une tranchée.
Patent CA-2615049-C (CA)
Inventor: ZIMMERMANN HOLGER
IPC: C07D417/12
Filed: 2006-07-01
Granted: 2013-12-03
Abstract: The invention relates to heterocyclylamide-substituted thiazoles, pyrroles and thiophenes and processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular for the use as antiviral agents, especially against cytomegaloviruses.
Patent CA-2615666-C (CA)
Inventor: SEIWERT SCOTT D
IPC: A61K38/00
Filed: 2006-07-17
Granted: 2014-08-26
Abstract: La présente invention concerne des composés de la formule générale (I) à la formule générale (VIII), ainsi que des compositions, comprenant des compositions pharmaceutiques, comprenant un composé sujet. La présente invention concerne également des procédés de traitement, comprenant des procédés de traitement de l~infection par le virus de l~hépatite C et des procédés de traitement de la fibrose hépatique, les procédés impliquant généralement l~administration à un individu nécessitant celle-ci une quantité efficace d~un composé ou d~une composition sujet.
Patent CA-2615807-C (CA)
Inventor: HENNESSY DAVID R
IPC: F16D35/02
Filed: 2006-07-28
Granted: 2015-11-24
Abstract: A viscous clutch assembly (100) includes a rotational input structure (110), a rotor (104) attached to the rotational input structure (110), a selectively rotatable member (102) surrounding the rotor (104) and rotatably supported by the rotational input structure (110), an electromagnetic coil (108) positioned relative to a driven side of the rotor (104), a valve assembly (106) supported by the rotor (104), and a magnetic flux circuit for controlling the valve assembly (106) with magnetic flux generated by the electromagnetic coil (108).  The valve assembly (106) includes a cover plate (140) for regulating flow of a shear fluid. The rotational input structure (110) comprises a material capable of conducting magnetic flux. The magnetic flux circuit is configured to include no more than four air gaps (G1-G4).
Patent CA-2624909-C (CA)
Inventor: KANEKO TAKASHI
IPC: A61P3/10
Filed: 2006-10-05
Granted: 2013-10-01
Abstract: A novel therapeutic agent for organ disease, in particular, a therapeutic agent for liver disease is provided. It has been found that a diarylsulfide or diarylether derivative having 2-amino-1,3-propanediol structure, the compound that act as a sphingosine-1-phosphate receptor agonist, and a pharmaceutically acceptable salt and hydrate thereof are used as effective therapeutic agents for various diseases in organs, in particular liver diseases. The diarylsulfide or diarylether derivative is represented by the following general formula (1): (see formula 1)
Patent CA-2627943-C (CA)
Title: Procedes de preparation de taxanes au moyen d'auxiliaires chiraux
Inventor: CARON GAETAN
IPC: C07F7/18
Filed: 2006-11-03
Granted: 2013-12-31
Abstract: L'invention concerne une synthèse stéréosélective de dimères de ß-lactams utilisés comme précurseurs utiles pour la préparation de paclitaxel, de docétaxel et des analogues de ceux-ci. Plus précisément, les ß-lactams sont préparés à partir d'auxiliaires chiraux facilement disponibles et purs sur le plan énantiomérique. Les ß-lactams sont ensuite mis à réagir avec un taxane protégé de manière appropriée, aux fins de production de taxanes porteurs de chaînes latérales enrichis sur le plan diastéréomère. Puis, l'auxiliaire chiral est clivé et des groupes de protection sont retirés de manière à obtenir le taxane souhaité.
Patent CA-2628621-C (CA)
Inventor: FRAWLEY LANNY J
IPC: H01R3/00
Filed: 2006-10-26
Granted: 2011-05-03
Abstract: An electrical unit has first and second attached housing sections. The sections are movable relative to one another and include internal conduits and conductors that extend between the sections.
Patent CA-2630755-C (CA)
Title: Procede permettant la production de diesel a faible teneur en soufre et de naphte a indice d'octane eleve
Inventor: THAKKAR VASANT PRAGJI
IPC: C10G69/10
Filed: 2008-05-06
Granted: 2015-03-17
Abstract: Un procédé permet la production de diesel à faible teneur en soufre et de naphte à indice d'octane élevé. L'effluent de distillat de la zone de réaction d'hydrodésulfurisation et l'effluent de la zone de réaction d'hydrocraquage auxquels sont ajoutés des matières désalkylées fortement aromatiques sont mélangés et séparés pour produire un flux d'hydrogène gazeux, du diesel à faible teneur en soufre et du naphte à indice d'octane élevé.
Patent CA-2631467-C (CA)
Inventor: WANG BIN
IPC: C12N15/86
Filed: 2006-12-22
Granted: 2016-11-22
Abstract: Compositions and kits for inhibiting an allergic response against an allergenic protein are disclosed. The compositions comprise a eukaryotic cell expression vector containing nucleotide sequences encoding an allergenic protein or a polypeptide that comprises an antigenic epitope of said allergenic protein; and an allergenic protein or a polypeptide that comprises an antigenic epitope of the allergenic protein. The kits comprise a first container which comprises a eukaryotic cell expression vector containing nucleotide sequences encoding an allergenic protein or a polypeptide that comprises an antigenic epitope of the allergenic protein and a second container which comprises an allergenic protein or a polypeptide that comprises an antigenic epitope of said allergenic protein. Compositions and kits for inhibiting an allergic response against an flea allergenic protein; a feline allergenic protein; a canine allergenic protein; a dust mite allergenic protein; a peanut allergenic protein; a Japanese cedar allergenic protein; and a blomia tropicalis allergenic protein are disclosed. Methods if using such compositions and kits are also disclosed.
Patent CA-2632554-C (CA)
Inventor: SHAKES JOHNATHAN J
IPC: G06F17/50
Filed: 2006-11-30
Granted: 2017-05-02
Abstract: Methods and apparatuses for the processing of receptacles containing heterogeneous inventory items in materials handling facilities are generally described. Dirty picking may be described as a mechanism for the "batch" processing of a receptacle which includes multiple heterogeneous inventory items with different identification codes in a materials handling facility as if all of the items in the receptacle have been ordered, even though one or more of the items may have not been ordered. Through the implementation of a dirty pick mechanism, instead of processing individual items in a receptacle, the entire receptacle may be "dirty picked" and all of the items within the receptacle may be processed "downstream" at a processing station, during which needed items for processing may be selected, and "overage" items may be put aside to be disposed, e.g. by being restocked.
Patent CA-2634546-C (CA)
Title: Carton with handle
Inventor: GOMES JEAN-MANUEL
IPC: B65D71/00
Filed: 2006-12-26
Granted: 2011-02-22
Abstract: A carton (190) has a handle (150) that allows a user to carry the carton when closed, and that extends to allow a user to carry the carton when the carton is in an open configuration. The carton includes gusseted end panels (180) that create a partially closed bottom receptacle (192) in the opened carton.
Patent CA-2635797-C (CA)
Inventor: MUDUMBA SREENIVASU
IPC: A61K47/34
Filed: 2007-02-09
Granted: 2015-03-31
Abstract: Described herein are formulations comprising therapeutic agents, including but not limited to formulations comprising rapamycin, pharmaceutical formulations, unit dose forms, kits, methods of preparing formulations, and methods of using formulations. Such formulations and methods have increased stability.
Patent CA-2637103-C (CA)
Inventor: LAURILA TIMO
IPC: C01F7/06
Filed: 2007-03-28
Granted: 2014-05-27
Abstract: The invention relates to a method that inhibits the formation of a deposition layer on metal surfaces in liquid submersion in a process susceptible to deposition, e.g. in an enrichment process. In the method, anodic current is supplied to the metal surface (11) to be protected against deposition via an external power source (100) and a cathode (12) immersed in the liquid, producing in the composition of the deposition adhering to the metal surface a change causing the adherence of the deposition to the surface (11) to be substantially weakened or the formation of deposition on a clean surface (11) to be substantially retarded.
Patent CA-2640482-C (CA)
Inventor: GOLDSTEIN SOLO
IPC: A61P25/00
Filed: 2007-01-30
Granted: 2011-04-19
Abstract: Composés de formule (I): dans laquelle : n représente un nombre entier compris entre 1 et 6 inclus, X représente un atome d'oxygène ou un groupement NR6, Y représente un atome de carbone ou un atome d'azote, Z représente un atome de carbone ou un atome d'azote, R1 et R2, représentent un atome d'hydrogène, ou un groupement alkyle ou arylalkyle, R3 et R4, représentent un atome d'hydrogène, ou un groupement alkyle, R5 représente un atome d'hydrogène, ou un groupement alkyle, halogène, hydroxy, alkoxy, cyano, nitro, acyle, alkoxycarbonyle, trihalogénoalkyle, trihalogénoalkoxy, amino éventuellement substitué, R6 représente un atome d'hydrogène, ou un groupement alkyle ou arylalkyle, Ra, Rb, Rc, Rd et Re, sont tels que définis dans la description, et leur utilisation comme ligands des recepteurs nicotiniques centraux du type .alpha.4.beta.2 pour le traitement des troubles neurodégénératifs et des troubles de l~humeur.
Patent CA-2640691-C (CA)
Inventor: HAYASHI CHIHIRO
IPC: B21D22/20
Filed: 2008-02-01
Granted: 2011-06-07
Abstract: In a method of producing an ultra thin wall metallic tube by a cold drawing process in which a drawing machine is used, a wall thickness of the metallic tube is reduced to perform drawing while a tube-wall centerline diameter of a tube material is expanded, using a solid die which gradually increases in diameter from its engaging inlet side toward its work-ending outlet side and a plug or a tapered mandrel bar which gradually increases in diameter over a corresponding distance from the engaging inlet side of the solid die toward the work-ending outlet side of the solid die, whereby the wall thickness can dramatically be reduced.
Patent CA-2642355-C (CA)
Inventor: WOBKER HANS-GUENTER
IPC: B22D11/124
Filed: 2008-10-30
Granted: 2016-02-16
Abstract: A liquid-cooled permanent chill mold for the continuous casting of metals, including a permanent chill mold plate (2) made of copper or a copper alloy and an adapter plate (3), on which the permanent chill mold plates (2) are fastened via fastening bolts (12). The permanent chill mold plates (3) are coupled to the adapter plates (3) via sheet metal holders (19) situated in their top regions and base regions (20, 21), in addition to via the fastening bolts (12).